BackAchilles Therapeutics Plc Overview

Achilles Therapeutics Plc Current Assets

Track Achilles Therapeutics Plc's current assets ($110M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$111.63M
28.21% YoYΔ $-43.87M vs prior year quarter

Peer trimmed avg / median

Loading

Achilles Therapeutics Plc Current Assets History

Loading

Achilles Therapeutics Plc vs. peers: Current Assets Comparison

Loading

Achilles Therapeutics Plc Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Achilles Therapeutics Plc (ACHL) FAQ

As of the most recent data (September 2024), ACHL shows a current assets of $110M. That compares with $160M in the prior-year period — down 28.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACHL's current assets is now $110M (was $160M) — a 28.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Achilles Therapeutics Plc is outperforming or lagging.

Tracking ACHL's current assets over time shows whether Achilles Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $160M in the prior-year period — down 28.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Achilles Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $110M) with ownership activity and broader fundamentals.

Achilles Therapeutics Plc's current assets is $110M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.